• Impact of Economic Downturn on Life Sciences Innovation and Venture Formation in Massachusetts
• Opportunity for Biomanufacturing in Massachusetts (download report)
• Life Sciences Human Capital Development (download report)
• Opportunity for Enhanced and Increased Clinical Trials in Massachusetts (download report)
• Increased Federal Funding for Life Sciences Research
  • Letter from Mass Life Sciences Collaborative Co-Chairs to Congressional Delegation
  • Press release

Additional Identified Priorities:

• Life Sciences Business Environment
  
• Transportation and Connectivity
  
• Housing issues as it impacts life sciences

Report: Massachusetts Clinical Trials Opportunity

This report highlights opportunities to improve and enhance clinical trials in Massachusetts. Clinical trials performed by our world- class academic health centers and hospitals can provide an invaluable service to our life sciences companies in securing prompt Federal approvals for their products, in improving the quality of the healthcare system by expediting the introduction of potentially breakthrough drugs and therapies to the community, and also in providing a source of additional revenue to the institutions themselves. Through a pro bono strategic effort with FletcherSpaght, Inc., the Life Sciences Collaborative conducted a data-driven analytical assessment of the clinical trials issues and challenges and investigated means to increase Phase II clinical trials and translational research.